Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin

NCT04166474 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Helen Reynolds

Collaborators